Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells
Crossref DOI link: https://doi.org/10.1186/s12885-017-3230-8
Published Online: 2017-03-29
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ariaans, Gerke
Jalving, Mathilde
Vries, Emma Geertruida Elisabeth de
Jong, Steven de
Funding for this research was provided by:
Koninklijke Nederlandse Akademie van Wetenschappen